| Literature DB >> 23586029 |
Igor Brasil-Costa1, Dayse O Alencar, Milene Raiol-Moraes, Igor A Pessoa, Alexandre W M Brito, Schneyder R Jati, Sidney E B Santos, Rommel M R Burbano, Andrea K C Ribeiro-dos-Santos.
Abstract
Ionizing radiation, such as that emitted by uranium, may cause mutations and consequently lead to neoplasia in human cells. The TP53 gene acts to maintain genomic integrity and constitutes an important biomarker of susceptibility. The present study investigated the main alterations observed in exons 4, 5, 6, 7, and 8 of the TP53 gene and adjacent introns in Amazonian populations exposed to radioactivity. Samples were collected from 163 individuals. Occurrence of the following alterations was observed: (i) a missense exchange in exon 4 (Arg72Pro); (ii) 2 synonymous exchanges, 1 in exon 5 (His179His), and another in exon 6 (Arg213Arg); (iii) 4 intronic exchanges, 3 in intron 7 (C → T at position 13.436; C → T at position 13.491; T → G at position 13.511) and 1 in intron 8 (T → G at position 13.958). Alteration of codon 72 was found to be an important risk factor for cancer development (P = 0.024; OR = 6.48; CI: 1.29-32.64) when adjusted for age and smoking. Thus, TP53 gene may be an important biomarker for carcinogenesis susceptibility in human populations exposed to ionizing radiation.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23586029 PMCID: PMC3613089 DOI: 10.1155/2013/303486
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Map of the study region. Red: Monte Alegre municipality; blue: Alenquer municipality; green: Prainha municipality; yellow: Belém city ([17, 18], adapted).
Target regions, primer sequences, and size of amplified fragments.
| Region | Target | Primer sequences | Product size (bp) |
|---|---|---|---|
| PIN3 | Intron 3 | 5′ GGGACTGACTTTCTGCTCTTGT 3′ | 147 or 163 |
| 5′ GGGACTGTAGATGGGTGAAAAG 3′ | |||
| Region 1 | Exon 4 | 5′ TTGCCGTCCCAAGCAATGGATGAT 3′ | 199 |
| 5′ TCTGGGAAGGGACAGAAGATGAC 3′ | |||
| Region 2 | Exon 5 and 6 | 5′ GCCGTCTTCCAGTTGCTTTA 3′ | 488 |
| 5′ TAACCCCTCCTCCCAGAGAC 3′ | |||
| Region 3 | Exon 7 | 5′ TTGGGCCTGTGTTATCTCCT 3′ | 253 |
| 5′ TGATGAGAGGTGGATGGGTAG 3′ | |||
| Region 4 | Exon 8 | 5′ CAAGGGTGGTTGGGAGTAGA 3′ | 331 |
| 5′ TGCTAGGAAAGAGGCAAGGA 3′ |
Figure 2Gender distribution in the study population.
Figure 3Comparison of age in populations exposed to radiation. Variation of age range with 2 standard deviations comparing the 3 populations according to the ages of the sampled individuals.
Description of cancer types found by municipality and survival.
| Population | Subject | Age (years) | Cancer type | Survival |
|---|---|---|---|---|
| Monte Alegre | 1 | 46 | Acute myeloid leukemia | 42 months |
| 2 | 26 | Lung cancer | 48 months | |
| 3 | 55 | Chronic lymphocytic leukemia | 49 months | |
| 4 | 24 | Osteosarcoma | 29 months | |
| Prainha | 5 | 19 | Chronic lymphocytic leukemia | 38 months |
| Alenquer | 6 | 54 | Gastric cancer | 48 months |
| 7 | 51 | Osteosarcoma | 35 months | |
| 8 | 44 | Hepatocarcinoma | 28 months |
Figure 4Nucleotide alterations found. (a) Arg72Pro; (b) 1 T → C exchange in third nucleotide of codon 179 (exon 5) that did not change the amino acid histidine; (c) rs800372; (d) rs7880172; (e) rs12947788; (f) rs12951053; (g) 1 T → G exchange in intron 8 at position 13,958.
Allele and genotype median frequencies observed TP53 gene from investigation populations.
| Frequencies | Arg72Pro (exon 4) | His179His (exon 5) | rs800372 (exon 6) | rs7880172 (intron 7) | rs12947788 (intron 7) | rs12951053 (intron 7) | 13,958 (intron 8) |
|---|---|---|---|---|---|---|---|
| GG 0.457 | TT 0.980 | AA 0.940 | CC 0.986 | CC 0.788 | TT 0.788 | TT 0.980 | |
| Genotype | GC 0.424 | TC 0.020 | AG 0.060 | CT 0.014 | CT 0.172 | TG 0.172 | TG 0.020 |
| CC 0.119 | CC 0.000 | GG 0.000 | TT 0.000 | TT 0.040 | GG 0.040 | GG 0.000 | |
| Allele | G 0.669 | T 0.990 | A 0.970 | C 0.993 | C 0.874 | T 0.874 | T 0.990 |
| C 0.331 | C 0.010 | G 0.030 | T 0.007 | T 0.126 | G 0.126 | G 0.010 |
Comparison between the allelic frequencies found in the study and described for the global population.
| Alterations | Allelic frequency | ||
|---|---|---|---|
| Study | Global [ |
| |
| Arg72Pro (exon 4) | 0.331 |
|
|
| His179His (exon 5) | 0.010 |
|
|
| rs800372 (exon 6) | 0.030 |
|
|
| rs7880172 (intron 7) | 0.007 |
|
|
| rs12947788 (intron 7) | 0.126 | 0.159 |
|
| rs12951053 (intron 7) | 0.126 |
|
|
| 13,958 (intron 8) | 0.010 |
|
|
Allele and genotype frequency observed in Arg72Pro from investigated and control populations.
| Populations | |||||
|---|---|---|---|---|---|
| Frequencies | Belém* | Monte Alegre | Prainha | Alenquer | |
| GG 0.482 | GG 0.404 | GG 0.520 | GG 0.449 | ||
| Genotype | GC 0.409 | GC 0.481 | GC 0.380 | GC 0.408 | |
| CC 0.109 | CC 0.115 | CC 0.100 | CC 0.143 | ||
| Allele | G 0.686 | G 0.644 | G 0.710 | G 0.653 |
|
| C 0.314 | C 0.356 | C 0.290 | C 0.347 | ||
*Control population.
Analysis by multiple logistic regression of the cancer association with risk factors.
| Variable | Value of | Odds ratio | Confidence interval (95%) |
|---|---|---|---|
|
| 0.024 | 6.48 | 1.29–32.64 |
| Age (over 50) | 0.098 | 3.92 | 0.78–19.80 |
| Smoking | 0.296 | 0.40 | 0.07–2.22 |